Researchers from the University of California at San Diego School of Medicine recently found via neuroimaging studies that brains of individuals with a history of anorexia or bulimia behave differently than those in the general population.
“Just 4,000 steps a day can lead to better brain health,” say University of California at Los Angeles (UCLA) experts on aging who recently published research results on exercise in the Journal of Alzheimer’s Disease.
A team of researchers from the University of California at San Diego (UCSD) and European Molecular Biology Laboratory (EMBL) has successfully created a three-dimensional molecular mapping system to examine how microbes affect skin.
BioMarin Pharmaceutical Inc. recently updated research results regarding an investigational gene therapy treatment for severe hemophilia A, presenting its findings at the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta.
Bullying, violence and other adversities witnessed or experienced by children and teens are likely to take a toll on their cardiovascular health, increasing chances of disease in adulthood, according to the American Heart Association (AHA).
People generally recognize the negative effects of drinking too much alcohol, but everyone may not know that drinking too much regularly can increase the risk of developing cancer, says the American Cancer Society (ACS).
Bryan Slaba, CEO of South Dakota’s Wagner Community Memorial Hospital - Avera (WCMH-A), recently received the American Hospital Association’s Rural Hospital Leadership Award for his achievements in local health outcomes.
Scientists at the University of California at Los Angeles (UCLA) recently demonstrated how high glucose levels in pregnant women may prevent babies’ heart cells from developing normally, shedding more light on congenital heart disease risk.
Restrictions placed on Bristol-Myers Squibb studies investigating regimens combining Opdivo (nivolumab) with existing treatments for previously unresponsive multiple myeloma cases have been partially rescinded by the Food and Drug Administration (FDA).
Seattle Genetics and Bristol-Myers Squibb revealed provisional results from their study considering the potential combination of Adcetris (brentuximab vedotin) and Opdivo (nivolumab) in treating relapsed or refractory Hodgkin lymphoma.
University of California at Los Angeles (UCLA) researchers recently created skeletal muscle cells using human stem cells, marking a significant step toward perfecting stem cell replacement therapy for muscle diseases such as Duchenne muscular dystrophy.